Literature DB >> 30637303

Increased Risk of Heterotopic Ossification Following Revision Hip Arthroplasty for Periprosthetic Joint Infection.

Jorge Manrique1,2, Pouya Alijanipour1,2, Snir Heller1,2, Michael Dove1,2, Javad Parvizi1,2.   

Abstract

BACKGROUND: To investigate whether surgery for Periprosthetic Joint Infection (PJI) of the hip, the number of procedures and their duration contribute to risk of Heterotopic Ossification formation.
METHODS: 56 patients with hip PJI undergoing one-stage (10) or two-stage (46) exchange arthroplasty were matched to 112 patients undergoing revision arthroplasty for aseptic failure based on age, gender, body mass index (BMI), surgical approach (all direct lateral) and date of surgery (2006-2013). Patients with Paget's disease and ankylosing spondylitis, or preoperative HO were excluded. Perioperative pain management included use of the anti-inflammatory medications in all patients without prophylactic radiotherapy. Six-month postoperative radiographs were reviewed based on Brooker classification.
RESULTS: The incidence of overall HO in PJI and aseptic groups was 84% (47/56) and 11% (12/112), respectively. High grade HO (grades 3 and 4) in PJI and aseptic groups were 25% (24/56) and 4% (4/112), respectively. PJI was an independent risk factor for HO in the multivariate analysis (odds ratio of 9.3, 95% CI: 2.9-29.9, P<0.001).
CONCLUSION: Patients undergoing surgical treatment of hip PJI seem to be at increased risk of developing HO compared to aseptic failure. HO prophylaxis regimens may be recommendable in eligible patients undergoing surgical intervention for PJI of the hip. LEVEL OF EVIDENCE: IV.

Entities:  

Keywords:  Heterotopic ossification; Hip; Periprosthetic joint infection; Revision arthroplasty

Year:  2018        PMID: 30637303      PMCID: PMC6310194     

Source DB:  PubMed          Journal:  Arch Bone Jt Surg        ISSN: 2345-461X


  25 in total

Review 1.  Heterotopic ossification after hip and knee arthroplasty: risk factors, prevention, and treatment.

Authors:  Richard Iorio; William L Healy
Journal:  J Am Acad Orthop Surg       Date:  2002 Nov-Dec       Impact factor: 3.020

Review 2.  Incidence of heterotopic bone formation after major hip surgery.

Authors:  Bruce Neal; Harley Gray; Stephen MacMahon; Louisa Dunn
Journal:  ANZ J Surg       Date:  2002-11       Impact factor: 1.872

3.  Current concepts in the development of heterotopic ossification.

Authors:  H C Pape; S Marsh; J R Morley; C Krettek; P V Giannoudis
Journal:  J Bone Joint Surg Br       Date:  2004-08

Review 4.  BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk.

Authors:  Kohei Miyazono; Shingo Maeda; Takeshi Imamura
Journal:  Cytokine Growth Factor Rev       Date:  2005-06       Impact factor: 7.638

Review 5.  Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis.

Authors:  Tracy A Balboni; Reuben Gobezie; Harvey J Mamon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-08-01       Impact factor: 7.038

6.  Reconstruction of bone defects with impacted allograft in femoral stem revision surgery.

Authors:  Alberto Francés; Enrique Moro; Juan-Luis Cebrian; Fernando Marco; Antonio García-López; David Serfaty; Luis López-Durán
Journal:  Int Orthop       Date:  2007-02-06       Impact factor: 3.075

7.  Risk factors for heterotopic ossification in total hip arthroplasty.

Authors:  S Eggli; A Woo
Journal:  Arch Orthop Trauma Surg       Date:  2001-10       Impact factor: 3.067

8.  Heterotopic ossification after revision total knee arthroplasty.

Authors:  Robert L Barrack; Christopher S Brumfield; Cecil H Rorabeck; Diana Cleland; Leann Myers
Journal:  Clin Orthop Relat Res       Date:  2002-11       Impact factor: 4.176

9.  BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing.

Authors:  Kunikazu Tsuji; Amitabha Bandyopadhyay; Brian D Harfe; Karen Cox; Sanjeev Kakar; Louis Gerstenfeld; Thomas Einhorn; Clifford J Tabin; Vicki Rosen
Journal:  Nat Genet       Date:  2006-11-12       Impact factor: 38.330

10.  [Risk factors associated with heterotopic ossifications in primary total hip arthroplasty].

Authors:  M Handel; J Brettschneider; F X Köck; S Anders; L Perlick; S Sell
Journal:  Z Orthop Ihre Grenzgeb       Date:  2004 Sep-Oct
View more
  3 in total

1.  How Can We Differentiate Local Recurrence From Heterotopic Ossification After Resection and Implantation of an Oncologic Knee Prosthesis in Patients with a Bone Sarcoma?

Authors:  Khodamorad Jamshidi; Abolfazl Bagherifard; Hamadalla Hadi Al-Baseesee; Alireza Mirzaei
Journal:  Clin Orthop Relat Res       Date:  2021-05-01       Impact factor: 4.176

2.  Heterotopic Ossification in Orthopaedic and Trauma surgery: A Histopathological Ossification Score.

Authors:  M Ohlmeier; V Krenn; D M Thiesen; N A Sandiford; T Gehrke; M Citak
Journal:  Sci Rep       Date:  2019-12-05       Impact factor: 4.379

3.  A Rare Case of Extremely Severe Heterotopic Ossification after Primary Total Hip Arthroplasty due to Persistent Mild Periprosthetic Joint Infection.

Authors:  Yutaka Kinoshita; Shunji Nakano; Shinji Yoshioka; Masaru Nakamura; Tomohiro Goto; Daisuke Hamada; Koichi Sairyo
Journal:  Case Rep Orthop       Date:  2021-05-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.